Organovo Holdings Inc (ONVO)

8.80 +0.24  +2.80% NASDAQ Jun 17, 16:14 USD
View Full Chart
Price Chart
View All ONVO News


View All Events


Date Type Description
08/10/2021 Earnings Results Q1 2022 Earnings Results
02/08/2021 Earnings Results Q3 2021 Earnings Results
11/05/2020 Earnings Results Q2 2021 Earnings Results
09/15/2020 12:00 EST AGM 2020 Annual General Meeting
08/19/2020 Splits 1 to 20 Split
08/10/2020 Earnings Results Q1 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports



  • Description: Organovo Holdings Inc is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo's key instrument platform is the NovoGen Bioprinter. The firm's 3-D bioprinting technologies create tissues using living cells and biocompatible hydrogels.
  • URL:
  • Investor Relations URL:
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Small Cap/Value
  • Next Earnings Release: Aug. 10, 2021
  • Last Earnings Release: Feb. 08, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A





Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.